Drug traceability related policies are initiated in many provinces affecting all pharmacies.

Pharmaceutical Network September 24th, Recently, Fujian Provincial Drug Administration held the province's drug information traceability system construction video promotion meeting, on the drug production and management enterprises of drug traceability progress, related deployment.
addition, on September 21, Hebei Provincial Drug Administration issued a notice, has officially launched the province's Chinese medicine tablets traceability work, 20 production enterprises and 77 franchise enterprises have been included in the retrospective scope for the first time.
can be said that in order to implement the Drug Administration Law and the State Drug Administration on drug information traceability system construction related work deployment, many provinces have entered the "accelerated period" to promote drug traceability work.
"reflow medicine" will become history On November 1, 2018, the State Drug Administration officially issued the Guidance on the Construction of the Drug Information Tracing System (hereinafter referred to as the Opinion).
The Opinions make it clear that drug listing license holders and production enterprises bear the primary responsibility for the construction of drug traceability systems, and pharmaceutical operating enterprises and user units shall, in cooperation with drug listing license holders and production enterprises, establish a complete drug traceability system and fulfill their respective retrospective responsibilities.
that is, the ecology of keeping only data from drug production to wholesale medicines will be changed in the past, and in the future, medicines can be traced directly to medical institutions and retail pharmacy terminals.
Combined with the Hebei Provincial Drug Administration issued "on the Chinese medicine tablets into the scope of drug circulation traceability notice", Hebei Province, Chinese medicine tablets production pilot enterprises, Chinese medicine tablets franchise enterprises and the drug wholesale and retail enterprises have been connected and adjusted in accordance with data standardization, data transmission interface docking and data upload three steps to implement the Chinese medicine tablets traceability data reporting work.
the completion of the relevant data upload work, from November 1, 2020, Hebei Province pharmaceutical enterprises will formally report the Chinese medicine tablets traceability data.
it is learned that as of August 2020, Hebei Province has 518 pharmaceutical wholesale enterprises, 386 retail chain headquarters (including 11,211 stores), 3,695 single pharmacies, to join the traceability system and report traceability data 350 million, initially formed a source can be traced, to traceable, responsibility traceable system.
It can be said that after the establishment of the future retrospective system, through health insurance, new agricultural co-operation and other means from hospitals or pharmacies to buy drugs, through illegal recyclers re-sold to pharmacies, clinics, and then sold to customers drugs, in order to take the health insurance fund sales of reflow drugs phenomenon will be nowhere to hide.
same time, in the daily flight inspection work, in view of the phenomenon of sales of reflow drugs, the regulatory authorities have carried out a number of inspection batches, check single number, examination of various types of drug purchase bills and other regulatory means will be more efficient.
pharmacies, compliance can survive in the long run, the establishment of drug traceability, there is no doubt that the compliance of pharmacy operations put forward higher requirements.
, how will this policy affect the entire pharmaceutical business when it comes to the various subjects of drug production and circulation? In this regard, Seber blue - pharmacy manager interview to the platform writer Code Wanxuan said that the drug traceability on pharmacies, and even the impact of pharmaceutical business, can be divided into several aspects: First, pharmacies become a part of the information tracing system, will inevitably be the pharmacy information construction, code of conduct mandatory requirements;
long-term impact of drug control, prescription outflow, and even pharmaceutical e-commerce and other aspects.
First, pharmaceutical businesses, pharmacies, if they participate in drug control and marketing, it may be difficult to avoid leaving traces in the time and space memory of the information-based traceability system; Production enterprises may ask for drug terminal sales records from the drug information traceability system, which will weaken the negotiating position of pharmaceutical businesses, pharmacies and pharmaceutical production enterprises;
can be said that once the drug traceability is carried out, pharmacies may have to face the above situation, and as the main operating body, pharmacies in the drug traceability construction work responsibility is also very clear.
Drug traceability, pharmacy responsibility is very clear in the specific drug circulation process, involving pharmacies as a sales terminal to assume the following responsibilities: pharmaceutical wholesale enterprises in the procurement of drugs, the need to obtain relevant retrospective information from upstream enterprises, in the drug acceptance check, and check the information back to upstream enterprises;
When purchasing drugs, the retail and user units of pharmaceuticals shall obtain relevant retrospective information from upstream enterprises, check them at the time of drug acceptance, and return the checking information to upstream enterprises;
.